GlycA Is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients With Type 2 Diabetes
Inflammation - United States
doi 10.1007/s10753-014-0107-8
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2015
Authors
Publisher
Springer Science and Business Media LLC